<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The pathological examination of material removed from patients with colorectal <z:hpo ids='HP_0002664'>neoplasia</z:hpo> is important </plain></SENT>
<SENT sid="1" pm="."><plain>It provides a wide range of information on, for example, the quality and completeness of excision, the stage and biological <z:hpo ids='HP_0000718'>aggressiveness</z:hpo>, the need for further therapy, and response to therapy </plain></SENT>
<SENT sid="2" pm="."><plain>Molecular testing adds valuable information on genetic risk and is required before treatment with anti-EGF-r antibodies </plain></SENT>
<SENT sid="3" pm="."><plain>This article highlights the value derived from macroscopic inspection of surgical specimens, careful microscopy and excellent reporting according to national guidelines </plain></SENT>
<SENT sid="4" pm="."><plain>Increasing use of a number of preoperative therapies and combinations in <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancer</z:e> change the pathological features found and a standardised approach to the diagnosis of complete response is required </plain></SENT>
<SENT sid="5" pm="."><plain>It touches upon the issues with frequent changes in TNM staging and the difficulties these changes are causing </plain></SENT>
<SENT sid="6" pm="."><plain>The widespread introduction of <z:e sem="disease" ids="C0346627" disease_type="Neoplastic Process" abbrv="">bowel cancer</z:e> screening is changing the stage of presentation of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> leading to increasing numbers of local excisions and <z:mpath ids='MPATH_491'>polyp</z:mpath> <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> </plain></SENT>
</text></document>